Losartan vs valsartan efficacy
Pro Research Analysisby 
Searched over 200M research papers
Comparative Efficacy of Losartan vs Valsartan in Hypertension
Blood Pressure Lowering Effectiveness: Losartan vs Valsartan
Multiple studies have directly compared the antihypertensive efficacy of losartan and valsartan in patients with mild to moderate essential hypertension. Both drugs are effective in lowering blood pressure, but some differences have been observed:
- One study found that valsartan provided significantly better antihypertensive efficacy than losartan, as shown by lower 24-hour, daytime, and nighttime ambulatory blood pressure monitoring (ABPM) values, a lower percentage of abnormal blood pressure readings, and a more consistent blood pressure-lowering effect throughout the day and night .
- Another study, however, reported that losartan and valsartan had similar antihypertensive effects overall, with no significant difference in the reduction of sitting diastolic blood pressure (SiDBP) after 12 weeks of treatment. The percentage of patients reaching blood pressure goals was also similar between the two drugs .
- A third study found that both drugs significantly reduced blood pressure, but losartan produced a more consistent blood pressure-lowering response across patients, with less variability and a more homogeneous effect over 24 hours .
Duration and Consistency of Blood Pressure Control
- Valsartan may offer a more homogeneous and sustained antihypertensive effect over 24 hours compared to losartan, as indicated by higher trough/peak ratios and smoothness indices .
- Losartan, on the other hand, showed a more consistent response among patients, with less variability in blood pressure reduction .
- Some research suggests that the duration of the blood pressure-lowering effect of losartan may not persist throughout 24 hours as well as valsartan, especially at lower doses .
Uric Acid Effects: A Key Difference
- Losartan has a unique benefit among angiotensin receptor blockers (ARBs) in that it significantly lowers serum uric acid levels, while valsartan does not. This effect has been consistently observed in both individual studies and meta-analyses 234.
- The reduction in uric acid with losartan may be clinically relevant for patients at risk of hyperuricemia or gout .
Tolerability and Safety
- Both losartan and valsartan are generally well tolerated, with similar safety profiles reported in head-to-head trials 23.
- No significant differences in adverse events have been consistently reported between the two drugs.
Cost-Effectiveness Considerations
- Economic modeling suggests that valsartan may be more cost-effective than losartan in terms of reducing cardiovascular events, but this advantage must be weighed against the potential cost savings of generic losartan and individual patient needs .
Conclusion
Losartan and valsartan are both effective and well-tolerated options for treating mild to moderate hypertension. Valsartan may provide a slightly more sustained and homogeneous blood pressure-lowering effect, while losartan offers the added benefit of reducing serum uric acid. The choice between these medications should consider individual patient characteristics, including the need for uric acid reduction and the importance of consistent 24-hour blood pressure control.
Sources and full results
Most relevant research papers on this topic